Skip to main content
Clinical Trials/NCT06456645
NCT06456645
Completed
Not Applicable

The Impacts of Maternal Smoking During Pregnancy on Breastfeeding and the Correlation of IGF, Leptin, HPL Expression in Placenta Tissue

Celal Bayar University1 site in 1 country70 target enrollmentMay 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking, Tobacco
Sponsor
Celal Bayar University
Enrollment
70
Locations
1
Primary Endpoint
100% Patients's placenta with smoking in Pregnancy and 100% Patients's Placenta with from non-smoking in Pregnancy. Placenta Tissues Staining Measured by immunohistochemistry and biochemistry technique.
Status
Completed
Last Updated
last year

Overview

Brief Summary

Maternal smoking during pregnancy although it is known to be associated with fetal growth restriction, it's effect on postpartum breastfeeding is not yet clear. The aim of the present study was to examine the impacts of smoking in pregnancy on breastfeeding as well as its impacts on placental immunoreactivity.

Detailed Description

The study was conducted on 70 women who gave birth via spontaneous vaginal delivery. Groups were classified as Smokers (n=35) and Non-smokers (n=35). The breastfeeding conditions of both groups were evaluated prior to discharge and after postpartum 10th day. Cross-sections were taken from the placenta tissues after which their IGF-1 (insulin like growth factor-1), Leptin, HPL (human placental lactogen) immunoreactivities were examined.

Registry
clinicaltrials.gov
Start Date
May 1, 2017
End Date
November 5, 2019
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant women who have started smoking at least 100 cigarettes in her lifetime and who now smokes every day,
  • Pregnant women who have never smoked throughout their life, including pregnancy(16),
  • Pregnant women who gave birth at term,
  • Multiple pregnancy, preeclampsia, gestational diabetes, thyroid dysfunction, those who do not have a systemic disease and due to systemic disease during pregnancy those who do not use
  • Pregnant women who had spontaneous vaginal delivery,
  • In order not to encounter communication barriers and because cultural differences may vary, the pregnant woman is not a foreign national,
  • Pregnant women who do not have any barriers to communication by phone,
  • Those who do not have any health problems that prevent breastfeeding

Exclusion Criteria

  • multiple pregnancy
  • insulin dependent diabetes
  • pregnant women who have had a cesarean section
  • preeclampsia
  • thyroid disease

Outcomes

Primary Outcomes

100% Patients's placenta with smoking in Pregnancy and 100% Patients's Placenta with from non-smoking in Pregnancy. Placenta Tissues Staining Measured by immunohistochemistry and biochemistry technique.

Time Frame: Baseline

Secondary Outcomes

  • Sociodemographic, birth history, and breastfeeding questions were measured by survey technique.(Baseline)

Study Sites (1)

Loading locations...

Similar Trials